[Oral gamma-linoleic acid (Epogam) in the treatment of atopic dermatitis].
D000284:Administration, Oral; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D005228:Fatty Acids, Essential / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D006801:Humans; D008041:Linoleic Acids; D031665:Oenothera biennis; D010938:Plant Oils; D017965:gamma-Linolenic Acid / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003879:Dermatologic Agents; D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D010938:Plant Oils; C028498:evening primrose oil; D017965:gamma-Linolenic Acid
Oral gammolensyre (Epogam) til behandling af atopisk dermatitis.